Trade names from 'clarithromycin-proteche' to 'clenzite-c' - Electronic medicinal guide TALKDRUGS

The tablets covered with a cover, on 250 mg.

Tablets, film-coated, 250 mg, 500 mg.

Film coated tablets, 250 mg and 500 mg.

BIOKOM TECHNOLOGY, LLC Republic of Belarus

Tablets 10 mg.

Film coated tablets, 250 mg and 500 mg.

Syrup 5 mg / 5 ml.

Powder for the preparation of solution for intravenous and intramuscular injection, 1000 mg + 500 mg.

Tablets, film-coated, 500 mg.

Powder for the preparation of a solution for injection of 0.5 g or 1 g of active substance in a vial.
Powder for the preparation of solution for intravenous and intramuscular injection.
Aventis Pharma Limited United Kingdom

Powder for the preparation of a suspension for oral administration 125 mg / 5ml.

Abbott SpA Italy

Lyophilizate for solution for infusion, 500 mg.

Abbott France France
Tablets, film-coated, 500 mg.
Abbott Sr.L. Italy

Tablets, film-coated, 250 mg.

Abbott SpA Italy

Tablets of prolonged action, film-coated, 500 mg.

Raw materials are vegetable crushed.
Solution for external use [alcohol].
Solution for external use alcohol.
Solution for external use alcohol.
VERTEKS, AO Russia
Solution for Injection 2000 anti-Ha IU / 0.2 ml; 4000 anti-Ha IU / 0.4 mL; 6000 anti-Ha IU / 0.6 mL; 8000 anti-Ha IU / 0.8 ml; 10,000 anti-Ha IU / 1

Solution for intravenous and intramuscular injection, 1 mg / ml.

Syrup, 1 μg / ml.
Sopharma, AO Bulgaria

Syrup, 1 μg / ml.

Tablets, 0.02 mg.

Sopharma, AO Bulgaria
Gel for external use 0,1%.

Gel for external use.